Dianthus Therapeutics To Participate in the 8th Annual Evercore Healthcare Conference
Rhea-AI Summary
Dianthus Therapeutics (Nasdaq: DNTH) will participate in the 8th Annual Evercore Healthcare Conference in Coral Gables, Florida. Marino Garcia, CEO, will join a fireside chat on December 2, 2025 at 2:35 p.m. ET and will hold one-on-one investor meetings.
A live webcast of the presentation may be accessed via the News and Events page in the Investors section of the Dianthus Therapeutics website.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, DNTH gained 5.38%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
NEW YORK and WALTHAM, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today announced the Company’s participation in the 8th Annual Evercore Healthcare Conference in Coral Gables, Florida. Marino Garcia, CEO of Dianthus Therapeutics, will participate in a fireside chat on Tuesday, December 2, 2025 at 2:35 p.m. ET and will host one-on-one meetings with investors.
A webcast of this presentation may be accessed under “News and Events” in the Investors section of the Dianthus Therapeutics website.
About Dianthus Therapeutics
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases. Based in New York City and Waltham, Mass., Dianthus is comprised of an experienced team of biotech and pharma executives who aim to deliver transformative medicines for people living with severe autoimmune and inflammatory diseases.
To learn more, please visit www.dianthustx.com and follow us on LinkedIn.
Contact
Jennifer Davis Ruff
Dianthus Therapeutics
jdavisruff@dianthustx.com